Becker's Healthcare October 15, 2024
Naomi Diaz

The Drug Enforcement Administration is signaling that it will extend flexibilities, enacted during the COVID-19 pandemic, that allows healthcare providers to prescribe specific controlled substances via telehealth, Politico reported Oct. 11.

Seven things to know:

  1. A new rule called “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” was sent to the White House for review on Oct. 10.
  2. According to Politico, it’s not yet known how long the extension will last.
  3. The possible delay means that either Vice President Kamala Harris or former President Donald Trump’s administration will have to address the issue.
  4. This extension would allow healthcare providers to prescribe specific controlled substances via telehealth. This includes stimulant medications for attention-deficit/hyperactivity disorder,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Telehealth gets short extension, physician pay is cut in spending bill
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congress Extends Hospice Telehealth Flexibilities
Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study
Senior Living Operators, Experts Urge Extension of Medicare Telehealth, Post-Acute Waivers

Share This Article